In the Philippines, access to comprehensive genomic profiling (CGP), circulating tumor DNA (ctDNA), and cell-free DNA (cfDNA) ...

Biomarker testing has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone.

Lung cancer cases are increasing in people who have never smoked, especially in women, a new study by the World Health ...

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Ridgefield, Conn., U.S., and Ingelheim, Germany <li /> Zongertinib would be the first orally administered, targeted therapy for ...

Reported encouraging early safety and efficacy data in ongoing dose escalation trial for ORIC-944 in combination with androgen receptor ...

Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a form of renal cell carcinoma (RCC) driven by a mostly inherited mutation.